CN: 32-1845/R
ISSN: 2095-6975
引用本文:
0
李梢, 张博. 中药网络药理学:理论、方法与应用[J]. 中国天然药物英文, 2013, 11(2): 110-120

中药网络药理学:理论、方法与应用

李梢, 张博
清华大学清华信息国家实验室生物信息学研究部/合成与系统生物学中心, 北京 100084
摘要:
中医学将病人当作一个具有不同状态的系统来进行治疗,具有悠久的历史,积累了大量的方剂。中医学的整体观念与网络药理学、网络生物学等前沿科技的核心思想具有相通之处,也符合了对肿瘤等复杂疾病进行系统性治疗的需求。"中药网络药理学"这一新领域的研究旨在从系统层次和分子水平揭示中药方剂的奥秘,促进中药研究从当前的"单一靶标,单一药物"模式转向"网络靶标,多成分药物"的新模式。近年来,中药网络药理学的一系列方法得以创建,包括基于网络的疾病基因预测、中药成分的靶标谱和药理活性预测、药物-基因-疾病的共模块分析、中药方剂多成分协同作用的大规模筛选、中药方剂的配伍规律和网络调节机理分析等。这些方法在清络饮、六味地黄丸等方剂的药效物质与作用机理等方面得到了有效应用。研究结果表明中药网络药理学能够为中医学从基于经验的医学迈向基于证据的医学提供新的途径,并能加速中药药物发现的进程,同时改进当前的药物研究策略。
关键词:    中医药    网络药理学    网络靶标    理论    方法    应用   
收稿日期: 2013-02-12
相关功能
PDF(1336 KB) Free
打印本文
把本文推荐给朋友
作者相关文章
李梢 在本刊中的所有文章
张博 在本刊中的所有文章
参考文献:
[1] Corson TW,Crews CM.Molecular understanding and modern application of traditional medicines:triumphs and trials[J].Cell,2007,130(5):769-774.
[2] Chan K.Progress in traditional Chinese medicine[J].Trends Pharmacol Sci,1995,16(6):182-187.
[3] Qiu J.Traditional medicine:a culture in the balance[J].Nature,2007,448(7150):126-128.
[4] Stone R.Lifting the veil on traditional Chinese medicine[J].Science,2008,319(5864):709-710.
[5] Wang L,Zhou GB,Liu P,et al.Dissection of mechanisms of Chinese medicinal formula Realgar-Indigo naturalis as an effective treatment for promyelocytic leukemia[J].Proc Natl Acad Sci USA,2008,105(12):4826-4831.
[6] Lam W,Bussom S,Guan F,et al.The four-herb Chinese medicine PHY906 reduces chemotherapy-induced gastrointestinal toxicity[J].Sci Transl Med,2010,2(45):45ra59.
[7] Hoessel R,Leclerc S,Endicott JA,et al.Indirubin,the active constituent of a Chinese antileukaemia medicine,inhibits cyclin-dependent kinases[J].Nat Cell Biol,1999,1(1):60-67.
[8] Yue QX,Cao ZW,Guan SH,et al.Proteomics characterization of the cytotoxicity mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network[J].Mol Cell Proteomics,2008,7(5):949-961.
[9] Park SJ,Ahmad F,Philp A,et al.Resveratrol ameliorates aging-related metabolic phenotypes by inhibiting cAMP phosphodiesterases[J].Cell,2012,148(3):421-433.
[10] Zhou H,Sun L,Yang XL,et al.ATP-directed capture of bioactive herbal-based medicine on human tRNA synthetase[J].Nature,2013,494(7435):121-124.
[11] Titov DV,Gilman B,He QL,et al.A subunit of TFIIH,is a target of the natural product triptolide[J].Nat Chem Biol,2011,7(3):182-188.
[12] Xu Z.Modernization:One step at a time[J].Nature,2011,480(7378):S90-S92.
[13] Keith CT,Borisy AA,Stockwell BR.Multicomponent therapeutics for networked systems[J].Nat Rev Drug Discov,2005,4(1):71-78.
[14] Jia J,Zhu F,Ma X,et al.Mechanisms of drug combinations:interaction and network perspectives[J].Nat Rev Drug Discov,2009,8(2):111-128.
[15] Schadt EE,Friend SH,Shaywitz DA.A network view of disease and compound screening[J].Nat Rev Drug Discov,2009,8(4):286-295.
[16] Levinson AD.Cancer therapy reform[J].Science,2010,328(5975):137.
[17] Li S.Possible relationship between traditional Chinese medicine ZHENG and molecular networks.The First Academic Annual Meeting of the China Association for Science and Technology.1999.
[18] Li S.Framework and practice of network-based studies for Chinese herbal formula[J].J Chin Integrat Med,2007,5(5):489-493.
[19] Li S,Zhang Z,Wu L,et al.Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network[J].IET Syst Biol,2007,1(1):51-60.
[20] Li S.Network systems underlying traditional Chinese medicine syndrome and herb formula[J].Curr Bioinformat,2009,4(3):188-196.
[21] Li S.Network target:a starting point for traditional Chinese medicine network pharmacology[J].China J Chin Mater Med,2011,36(15):2017-2020.
[22] Li S,Zhang B,Zhang NB.Network target for screening synergistic drug combinations with application to traditional Chinese medicine[J].BMC Syst Biol,2011,5(S1):S10.
[23] Zhao S,Li S.Network-based relating pharmacological and genomic spaces for drug target identification[J].PLoS ONE,2010,5(7):e11764.
[24] Wu X,Jiang R,Zhang MQ,et al.Network-based global inference of human disease genes[J].Mol Syst Biol,2008,4:189.
[25] Yao X,Hao H,Li Y,et al.Modularity-based credible prediction of disease genes and detection of disease subtypes on the phenotype-gene heterogeneous network[J].BMC Syst Biol,2011,5:79.
[26] Li S,Wu LJ,Zhang ZQ.Constructing biological networks through combined literature mining and microarray analysis:a LMMA approach[J].Bioinformatics,2006,22(17):2143-2150
[27] Huang Y,Li S.Detection of characteristic sub pathway network for angiogenesis based on the comprehensive pathway network[J].BMC Bioinformatics,2010,11(S1):S32.
[28] Gu J,Chen Y,Li S,et al.Identification of responsive gene modules by network-based gene clustering and extending:application to inflammation and angiogenesis[J].BMC Syst Biol,2010,4:47.
[29] Gu J,Li S.Towards integrative annotating of the cell-type specific gene functional and signaling map in vascular endothelial cells[J].Mol Biosyst,2012,8(8):2041-2049.
[30] Chen Y,Gu J,Li D,et al.Time-course network analysis reveals TNF-alpha can promote G1/S transition of cell cycle in vascular endothelial cells[J].Bioinformatics,2012,28(1):1-4.
[31] Li S,Zhang B,Jiang D,et al.Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae[J].BMC Bioinformatics,2010,11(S11):S6.
[32] Li LS,Zhang NB,Li S.Ranking effects of candidate drugs on biological process by integrating network analysis and Gene Ontology[J].Chin Sci Bull,2010,55(26):2974-2980.
[33] Yan H,Zhang B,Li S,et al.A formal model for analyzing drug combination effects and its application in TNF-alpha-induced NFkappaB pathway[J].BMC Syst Biol,2010,4:50.
[34] Zhao S,Li S.A co-module approach for elucidating drugdisease associations and revealing their molecular basis[J].Bioinformatics,2012,28:955-961.
[35] Li S,Zhao S.Network-based identification of drug target and drug action:China,201010218468.X[P].2010-10-21.
[36] Li S,Zhang NB,Zhang B.Method of network-based identification of multicomponent synergy and compositions for use as effective component of anti-angiogenesis medicines:US,8112230 B2[P].
[37] Li S,Zhang N,Zhang B.Network-based identification of synergistic drug combination:China,ZL200810239284.4[P].2008-10-23.
[38] Zhuang YL,Li S,Li YD.dbNEI:a specific database for neuro-endocrine-immune interactions[J].Neuro Endocrinol Lett,2006,27(1-2):53-59.
[39] Zhang J,Ma T,Li Y,et al.dbNEI2.0:building multilayer network for drug-NEI-disease[J].Bioinformatics,2008,24(20):2409-2411.
[40] Li S,Zhang B,Yuan J.A HerbBioMap database.China Software Copyright:2011SR076502.
[41] Zhang B,Liu L,Zhao S,et al.Vitexicarpin acts as a novel angiogenesis inhibitor and its target network[J].Evid Based Complement Alternat Med,2013:278405.
[42] Zhang B,Wang X,Li S.An integrative platform of TCM network pharmacology and its application on an herbal formula,Qing-LuoYin[J].Evid Based Complement Alternat Med,2013:456747.
[43] Ma T,Tan C,Zhang H,et al.Bridging the gap between traditional Chinese medicine and systems biology:the connection of Cold Syndrome and NEI network[J].Mol Bio Syst,2010,6(4):613-619.
[44] Jiang B,Liang X,Chen Y,et al.Integrating next-generation sequencing and traditional tongue diagnosis to determine tongue coating microbiome[J].Sci Rep,2012,2:936.
[45] Hopkins AL.Network pharmacology[J].Nature Biotechnol,2007,25(10):1110-1111.
[46] Hopkins AL.Network pharmacology:the next paradigm in drug discovery[J].Nature Chem Biol,2008,4(11):682-690.
[47] Schadt EE.Molecular networks as sensors and drivers of common human diseases[J].Nature,2009,461(7261):218-223.
[48] Barabási AL,Gulbahce N,Loscalzo J.Network medicine:a network-based approach to human disease[J].Nat Rev Genet,2011,12(1):56-68.
[49] Hoeng J,Deehan R,Pratt D,et al.A network-based approach to quantifying the impact of biologically active substances[J].Drug Discov Today,2012,17(9-10):413-418.
[50] Li S,Lu A,Wang Y,et al.Suppressive effects of a Chinese herbal medicine Qing-Luo-Yin extract on the angiogenesis of collagen induced arthritis in rats[J].Am J Chinese Med,2003,31(5):713-720.
[51] Jan van der Greef.Perspective:All systems go[J].Nature,2011,480:S87
[52] Ji ZL,Zhou H,Wang JF,et al.Traditional Chinese medicine information database[J].J Ethnopharmacol,2006,103(3):501.
[53] Chen CY.TCM Database@Taiwan:the world's largest traditional Chinese medicine database for drug screening in silico[J].PLoS One,2011,6(1):e15939.
[54] Fang YC,Huang HC,Chen HH,et al.TCMGeneDIT:a database for associated traditional Chinese medicine,gene and disease information using text mining[J].BMC Complement Altern Med,2008,8:58.
[55] Fang X,Shao L,Zhang H,et al.CHMIS-C:a comprehensive herbal medicine information system for cancer[J].J Med Chem,2005,48(5):1481-1488.
[56] Xue R,Fang Z,Zhang M,et al.TCMID:Traditional Chinese Medicine integrative database for herb molecular mechanism analysis[J].Nucleic Acids Res,2013,41:D1089-D1095.
[57] Goel R,Harsha HC,Pandey A,et al.Human Protein Reference Database and Human Proteinpedia as resources for phosphoproteome analysis[J].Mol Biosyst,2012,8(2):453-463.
[58] Licata L,Briganti L,Peluso D,et al.MINT,the molecular interaction database:2012 update[J].Nucleic Acids Res,2012,40:D857-D861.
[59] Franceschini A,Szklarczyk D,Frankild S,et al.STRING v9.1:protein-protein interaction networks,with increased coverage and integration[J].Nucleic Acids Res,2013,41:D808-D815.
[60] Xenarios I,Salwínski L,Duan XJ,et al.DIP,the Database of Interacting Proteins:a research tool for studying cellular networks of protein interactions[J].Nucleic Acids Res,2002,30(1):303-305.
[61] Chatr-Aryamontri A,Breitkreutz BJ,Heinicke S,et al.The BioGRID interaction database[J].Nucleic Acids Res,2013,41:D816-D823.
[62] Hamosh A,Scott AF,Amberger JS,et al.Online Mendelian Inheritance in Man(OMIM),a knowledgebase of human genes and genetic disorders[J].Nucleic Acids Res,2005,33:D514-D517.
[63] Bodenreider O.The Unified Medical Language System(UMLS):integrating biomedical terminology[J].Nucleic Acids Res,2004,32:D267-D270.
[64] Robinson PN,Mundlos S.The Human Phenotype Ontology[J].Clin Genet,2010,77:525-534.
[65] Yue QX,Cao ZW,Guan SH,et al.Proteomics characterization of the cytotoxicity mechanism of ganoderic acid D and computer-automated estimation of the possible drug target network[J].Mol Cell Proteomics,2008,7(5):949-961.
[66] Zhao J,Jiang P,Zhang W.Molecular networks for the study of TCM pharmacology[J].Brief Bioinform,2010,11(4):417-430.
[67] Wang Y,Liu Z,Li C,et al.Drug target prediction based on the herbs components:the study on the multitargets pharmacological mechanism of qishenkeli acting on the coronary heart disease[J].Evid Based Complement Alternat Med,2012:698531.
[68] Jiang M,Lu C,Chen G,et al.Understanding the molecular mechanism of interventions in treating rheumatoid arthritis patients with corresponding traditional Chinese medicine patterns based on bioinformatics approach[J].Evid Based Complement Alternat Med,2012:129452.
[69] Zhang A,Sun H,Yang B,et al.Predicting new molecular targets for rhein using network pharmacology[J].BMC Syst Biol,2012,6:20.
[70] Sun Y,Zhu R,Ye H,et al.Towards a bioinformatics analysis of anti-Alzheimer's herbal medicines from a target network perspective[J].Brief Bioinform,2012 Aug 11.
[71] Li X,Xu X,Wang J,et al.A system-level investigation into the mechanisms of Chinese Traditional Medicine:Compound Danshen Formula for cardiovascular disease treatment[J].PLoS One,2012,7(9):e43918.
[72] W Dai,JX Chen,P Lu,et al.Pathway pattern-based prediction of active drug components and gene targets from H1N1 influenza's treatment with Maxingshigan-Yinqiaosan Formula[J].Mol Biosyst,2013,9(3):375-385.
[73] Tao W,Xu X,Wang X,et al.Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease[J].J Ethnopharmacol,2013,145(1):1-10.